Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Skin, Basal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06398418
What this trial is testing

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid TumorMelanoma+3 more
Rise Therapeutics LLC 33
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Not applicableStudy completedNCT00574392
What this trial is testing

Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo

Who this might be right for
Basal Cell CarcinomaMelanomaNon-Malignant Skin Disorders+1 more
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Not applicableLooking for participantsNCT03889899
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 30
Early research (Phase 1)Study completedNCT00098943
What this trial is testing

NGR-TNF in Treating Patients With Advanced Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerKidney Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 70
Not applicableStudy completedNCT00005660
What this trial is testing

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Who this might be right for
Basal Cell CarcinomaKeratosis Palmaris et PlantarisPsoriasis
National Cancer Institute (NCI) 130
Large-scale testing (Phase 3)Study completedNCT00066872
What this trial is testing

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
Queen's Medical Center 500
Testing effectiveness (Phase 2)Study completedNCT01108094
What this trial is testing

Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma (BCC)Skin Cancer
Stanford University 29
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Not applicableUnknownNCT01265472
What this trial is testing

Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy

Who this might be right for
Squamous Cell CarcinomaBasal Cell Carcinoma
Rambam Health Care Campus 100
Not applicableActive Not RecruitingNCT03285230
What this trial is testing

The French E3N Prospective Cohort Study

Who this might be right for
Breast CancerColo-rectal CancerParkinson Disease+11 more
Institut National de la Santé Et de la Recherche Médicale, France 100,000
Not applicableStudy completedNCT01245972
What this trial is testing

Pilot Study of PDL to Treat BCC and SCCIS

Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma in Situ
University of California, San Diego 23
Post-approval studies (Phase 4)Study completedNCT00847912
What this trial is testing

CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial

Who this might be right for
Carcinoma, Basal CellCarcinoma, Squamous CellSkin Neoplasms+4 more
VA Office of Research and Development 954
Testing effectiveness (Phase 2)Study completedNCT02667574
What this trial is testing

Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)

Who this might be right for
Basal Cell Carcinoma
University Hospital, Lille 55
Large-scale testing (Phase 3)Study completedNCT00472459
What this trial is testing

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Who this might be right for
Actinic KeratosisWartsBasal Cell Carcinoma+2 more
Galderma R&D 82
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Not applicableStudy completedNCT06705608
What this trial is testing

Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study

Who this might be right for
Multiple SclerosisSkin CancerSkin Cancer Melanoma+3 more
University of British Columbia 4,000
Next Page